Fonstein Michael 4
4 · CLEVELAND BIOLABS INC · Filed Mar 22, 2011
Insider Transaction Report
Form 4
Fonstein Michael
DirectorCEO, President
Transactions
- Award
Employee Stock Options (Right to Buy)
2011-03-21+149,609→ 149,609 totalExercise: $7.16From: 2011-03-21Exp: 2021-03-20→ Common Stock (149,609 underlying)
Holdings
- 105,000
Employee Stock Options (Right to Buy)
Exercise: $3.44From: 2010-05-18Exp: 2020-05-17→ Common Stock (105,000 underlying) - 37,500
Employee Stock Options (Right to Buy)
Exercise: $8.36From: 2007-04-06Exp: 2017-04-05→ Common Stock (37,500 underlying) - 137,250
Employee Stock Options (Right to Buy)
Exercise: $4.00From: 2008-02-04Exp: 2018-02-03→ Common Stock (137,250 underlying)
Footnotes (1)
- [F1]On March 21, 2011, with the approval of the Compensation Committee, Cleveland BioLabs, Inc. issued stock options to Mr. Fonstein per the 2010 Executive Compensation Plan.